Stryker Corporation (SYK)
Stryker to Report Q1 Earnings: What's in Store for the Stock?
SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.
Wall Street's Insights Into Key Metrics Ahead of Stryker (SYK) Q1 Earnings
Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.
Stryker (SYK) Earnings Expected to Grow: Should You Buy?
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Stryker (SYK) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Foresight Capital Management Advisors Inc. Buys New Position in Stryker Corporation $SYK
Foresight Capital Management Advisors Inc. bought a new stake in shares of Stryker Corporation (NYSE: SYK) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,010 shares of the medical technology company's stock, valued at approximately $1,058,000. Several other large investors
Here's Why Stryker (SYK) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Stryker to Acquire AVS, Adding IVL Capabilities to Vascular Portfolio
SYK to acquire Amplitude Vascular Systems, adding next-gen IVL tech to boost its peripheral vascular portfolio and expand arterial disease treatment reach.
Here's Why Stryker (SYK) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?
ISRG outpaces SYK with stronger growth, robotic surgery dominance, and recurring revenue strength, highlighting its edge in MedTech innovation and market leadership.
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker rides on double-digit growth and robotics demand into 2026, but tariffs, vascular weakness and international hurdles cloud its near-term outlook.
Banco Bilbao Vizcaya Argentaria S.A. Has $22.99 Million Stock Position in Stryker Corporation $SYK
Banco Bilbao Vizcaya Argentaria S.A. reduced its stake in Stryker Corporation (NYSE: SYK) by 5.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 62,198 shares of the medical technology company's stock after selling 3,472 shares during the period. Banco Bilbao Vizcaya
Ameriprise Financial Inc. Cuts Stock Position in Stryker Corporation $SYK
Ameriprise Financial Inc. cut its position in shares of Stryker Corporation (NYSE: SYK) by 4.2% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,313,989 shares of the medical technology company's stock after selling 57,309 shares during the quarter. Ameriprise Financial Inc.
